NEPH News and Press, Nephros Inc. From 07/27/22

SOUTH ORANGE, NJ - ( NewMediaWire ) - July 27, 2022 - Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its second-quarter financial results on We...

Second Quarter Revenue of $2.9 Million, Year-Over-Year Increase of 27%; Number of Active Customer Sites Climbs 21% Year-Over-Year SOUTH ORANGE, NJ - ( NewMediaWire ) - July 06, 2022 -  Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and...

Nephros (NASDAQ:NEPH) said the U.S. Food and Drug Administration granted 510(k) clearance to its second-generation HDF Assist Module to provide hemodiafiltration (HDF) therapy to patients with end-stage renal disease (ESRD). The company said its HDF Assist Module is the first and only de...

The First and Only FDA-Cleared Device Available in the United States to Provide Hemodiafiltration Therapy to Dialysis Patients SOUTH ORANGE, NJ - ( NewMediaWire ) - May 17, 2022 - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and patho...

Rattler Midstream RTLR +14% Diamondback Energy to buy Rattler Midstream in all-stock deal. Spirit Airlines SAVE +14% on new tender offer from JetBlue. AgriFORCE Growing Systems (AGRI) +15%. NanoViricides (NNVC) +14% reports that it has begun drug development to combat...

Nephros, Inc. (NEPH) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Kirin Smith - President, PCG Advisory Andy Astor - President and Chief Executive Officer Wes Lobo - Chief Commercial Officer Conference Call Participants Anthony Vendetti - Maxim Group Sahil Kazm...

Gainers: AxoGen (AXGN) +26%. Better Therapeutics (BTTX) +15%. Intercept Pharmaceuticals (ICPT) +13%. XORTX Therapeutics (XRTX)  +13%. Belite Bio (BLTE) +8%. Losers: Nephros (NEPH) -32%. BioAtla (BCAB) -27%. Outset Medical (OM) -10%. ...

Nephros press release (NASDAQ:NEPH): Q1 GAAP EPS of -$0.20 misses by $0.09. Revenue of $2.18M (-19.3% Y/Y) misses by $0.92M. Shares -24.7% AH. For further details see: Nephros GAAP EPS of -$0.20 misses by $0.09, revenue of $2.18M misses by $0.92M

First Quarter Net Revenue of $2.2 Million; Active Customer Sites Climb 17% to New Record SOUTH ORANGE, NJ, May 04, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen dete...

SOUTH ORANGE, NJ - (NewMediaWire) - April 27, 2022 - Nephros, Inc.   (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its first-quarter financial result...